BioROSA Technologies Inc.

Creating a biologically-based diagnostic standard of care for autism spectrum disorders

Team

Marie Causey

CSO

John Slattery

CEO

Company details

Over 30 million children and over 100 million people around the world live with autism spectrum disorders (ASD). BioROSA is challenging the status quo by developing cost-effective, fast, and simple diagnostic tools to allow clinicians to easily determine who is at risk for ASD, simplify the diagnostic process, and enable therapeutic developments. We do this through powerful blood-based biomarkers and machine learning tools.

Get In Touch with BioROSA Technologies Inc.

Please tell us a little bit about yourself and why you'd like to get connected. BioROSA Technologies Inc. + SOSV will follow up with you via email.

Hidden
Hidden
Hidden
Hidden

No Offer, Solicitation, Advice, or Recommendation

Except to the extent expressly set forth in materials as may be provided through a password protected area on the SOSV website (the "Materials"), or as otherwise expressly specified by SOSV in writing, nothing on the SOSV website or on any platform or other communications medium owned, operated or otherwise by or on behalf of SOSV, is intended to constitute (i) an offer, or solicitation of an offer, to purchase or sell any security, other asset or service, (ii) investment advice or an offer to provide such advice, or (iii) a basis for making any investment decision. Except as expressly stated by SOSV in writing, neither the SOSV website or any platform or other communications medium owned, operated or otherwise by or on behalf of SOSV, nor any of the Materials make any effort to present a comprehensive or balanced description of SOSV or its investment activities. Please note the SOSV Communication Policy available here.